Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers CofiledCriticalBristol Myers Co
Publication of DK132028BpublicationCriticalpatent/DK132028B/da
Application grantedgrantedCritical
Publication of DK132028CpublicationCriticalpatent/DK132028C/da
C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
DK578971A1970-11-271971-11-26Analogifremgangsmade til fremstilling af en racemisk eller optisk aktiv penicillinforbindelse eller et salt heraf
DK132028C
(da)
Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive alfa-aminocyclohexadienylalkylen-penicilliner eller -cephalosporiner eller salte deraf.
Analogifremgangsmåde til fremstilling af racemisk eller optisk aktiv 1-isopropylamino-3-(4-(2-isopropylkarbamoylaminoætyl)-fenoxy)-propanol-2 eller syreadditionssalte deraf.
Analogifremgangsmåde til fremstilling af racemisk eller optisk aktivt 1-(2-nitrilophenoxy)-2-hydroxy-3-ethylaminopropan eller syreadditionssalte heraf.
Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropaner eller fysiologisk tålelige syreadditionssalte heraf.